Galvokimig(TD-HS856206) is a research-grade recombinant antibody targetingCTLA-8. Produced in mammalian cells with native-like glycosylation.HighlightsResearch Grade— For PK/PD studies, assay development, and ADA research.Native Glycosylation— Mammalian expression ensures native-like patterns.
Species reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Protein A/G purified from cell culture supernatant.
Accession
Q16552, Q96PD4 & P35225 & P02768
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names
Trispecific, Trivalent, 2648456-30-6
Background
Galvokimig is an anti-IL13/IL17A/ALB/IL17B monoclonal antibody.
Caption
SDS-PAGE for Research Grade Galvokimig. | Detects recombinant IL13 (Catalog No:TD-HW632012) in indirect ELISA. ### Detects recombinant human albumin (Catalog No:TD-HY411021) in indirect ELISA.
Note
For research use only. Not suitable for clinical or therapeutic use.
抗体
试剂盒
多肽
蛋白
组织芯片
定制服务咨询